Operationally, GLP-1 therapies have also increased the administrative burden
The goal is to reduce inventory in North 40 to make more room for Nuvia Wellness
For weight management , certain GLP-1 formulations (liraglutide 3.0mg [Saxenda] and semaglutide 2.4mg [Wegovy]) are licensed for chronic weight management in adults with: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidaemia) However, NHS access to these medications for weight management is typically restricted to specialist tier 3 or tier 4 weight management services, with specific eligibility criteria defined by NICE technology appraisals (TA494 for liraglutide, TA664 for semaglutide) and local commissioning arrangements
Post-reconstitution: 2-4 weeks at 2-8C, 1-3 months at -20C (aliquoted)
it therefore enrolled fewer patients and was shorter in duration than would be required to show safety in a post-approval setting, and was not powered to show superiority [79, 95]